Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MAXR
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics n.A.
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -2.41 0.81 0.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -8.67 49.04 -53.70
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value inf 0.00 18.67
Cash inf 0.00 0.70
Capex inf 0.00 -1.25
Free Cash Flow inf 0.00 0.55
Revenue inf 0.00 4.39
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 104.55 0.39 0.19
Operating Margin -92.13 0.02 -0.27
ROA 89.07 < 0.005 -0.02
ROE 88.79 < 0.005 -0.08
ROIC -91.18 < 0.005 -0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MAXR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MAXR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MAXR is permitted for members.